Vitamin D is an important determinant for the regulation of calcium and phosphorus levels and mineralization of the bone. The most reliable indicator of vitamin D status is the measurement of plasma or serum 25OH-D concentration. Several studies reported discrepancies between the results of assays. These high variabilities in 25OH-D measurements are due to used assay technologies and lack of standardization against the reference materials. Different assays have been employed for the measurement of 25OHD levels: Competitive Protein Binding Assays, immunoassays, direct detection methods. Choosing an assay platform is important both for clinical laboratory professionals and researchers, and several factors affect this process. Recently, liquid chromatography and tandem mass spectrometry is an alternative method to traditional assays and provides higher specificity and sensitivity than many assays; therefore, it has been suggested as a candidate reference method for circulating 25OH-D3. Standardization of methods for the quantification of 25OH-D by using the human-based samples would reduce the inter-method variability. The best way for laboratories to demonstrate the accuracy of their results is by participating in the external quality assessment scheme. Standardization of the assays is also required to provide clinicians with the accurate tools to diagnose hypovitaminosis. In addition, assay-specific decision limits are needed to define appropriate thresholds of treatment.
1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81.
2. Gupta A, Sjoukes A, Richards D, Banya W, Hawrylowicz C, Bush A, Saglani S. Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. Am J Respir Crit Care Med 2011; 184(12): 1342-9.
3. Ertek S, Akgül E, Cicero AF, Kütük U, Demirta S, Cehreli S, Erdo an G. 25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women. Arch Med Sci 2012; 8(1): 47-52.
4. Caprio M, Mammi C, Rosano GM. Vitamin D: a novel player in endothelial function and dysfunction. Arch Med Sci 2012; 8(1): 4-5.
5. Prietl B, Pilz S, Wolf M, Tomaschitz A, Obermayer-Pietsch B, Graninger W, Pieber TR. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vi - tamin D treatment for autoimmune diseases? Isr Med Assoc J 2010; 12(3): 136-9.
6. Motiwala SR, Wang TJ. Vitamin D and cardiovascular di se - a se. Curr Opin Nephrol Hypertens 2011; 20(4): 345-53.
7. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010; 74(1): 27-32.
8. Trump DL, Deeb KK, Johnson CS. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 2010; 16(1): 1-9.
9. Churilla TM, Brereton HD, Klem M, Peters CA. Vitamin D Deficiency Is Widespread in Cancer Patients and Cor - re la tes With Advanced Stage Disease: A Community Onco lo gy Experience. Nutr Cancer 2012; DOI:10. 1080/01635581.2012.661515.
10. Ginde AA, Liu MC, Camargo CA Jr. Demographic diffe - rences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169(6): 626-32.
11. Holick MF and Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87(suppl): 1080S-1086S.
12. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80: 1689S-1696S.
13. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hy - droxy vitamin D. J Clin Endocrinol Metab 2008; 93: 677-81.
14. Bringhurst RF, Demay MB, Kran SM, Kronenberg HM. Bone and Mineral Metabolism in Health and Disease, Chapter 23 in Harrison’s Endocrinology. Jameson JL, editor. McGraw-Hill Medical Publishing Division 2006.
15. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accu - racy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Bio - chem 2008; 45(Pt 2): 153-9.
16. Edelstein S. The assessment of vitamin D status. Proc Nutr Soc 1973; 32: 255-8.
17. Wilson PW, Lawson DE, Kodicek E. Gas-liquid chroma - tography of ergocalciferol and cholecalciferol in nano - gram quantities. J Chromatogr 1969; 39(1): 75-7.
18. Sheppard AJ, Prosser AR, Hubbard WD. Gas chromatography of the fat-soluble vitamins: a review. J Am Oil Chem Soc 1972; 49(11): 619-33.
19. Edelstein S, Lawson DEM, Kodicek E. The transporting proteins of cholecalciferol and 25-Hydroxycholecalciferol in serum of chicks and other species. Biochem J 1973; 135: 417-26.
20. Belsey RE, Deluca HF, Potts Jr JT. Competitive binding assay for vitamin D and 25-OH vitamin D. J Clin Endo - crinol Metab 1971; 33(3): 554-7.
21. Haddad HG, Chyu KJ. Competative protein-binding radio assay for 25-hydroxycholecalciferol. J Clin Endo crinol Me tab 1971; 33(6): 992-5.
22. Edelstein S, Charman M, Lawson DE, Kodicek E. Com - petitive protein-binding assay for 25-hydroxycholecalciferol. Clin Sci Mol Med 1974; 46(2): 231-40.
23. Carter GD. Accuracy of 25-Hydroxyvitamin D Assays: Confronting the Issues. Current Drug Targets 2011; 12: 19-28.
24. Hollis BW, Napoli JL. Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem 1985; 31: 1815-9.
25. Hollis BW. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr 2008; 88(suppl): 507S-510S.
26. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with a 125I-labelled tracer. Clin Chem 1993; 39: 529-53.
27. Carter GD, Carter R, Jones J, Berry J. How accurate are assays for 25-hydroxyvitamin D? Data from the Inter - national Vitamin D External Quality Assessment Scheme. Clin Chem 2004; 50: 2195-7.
28. Ong L, Saw S, Sahabdeen NB, Tey KT, Ho CS, Sethi SK. Current 25-hydroxyvitamin D assays: Do they pass the test? Clin Chim Acta 2012; 413: 1127-34.
29. Belsey RE, Deluca HF, Potts Jr JT. A rapid assay for 25- OH-vitamin D3 without preparative chromatography. J Clin Endocrinol Metab 1974; 38: 1046-51.
30. Leino A, Turpeinen U, Koskinen P. Automated Measure - ment of 25-OH Vitamin D3 on the Roche Modular E170 Analyzer. Clin Chem 2008; 54(12): 2059-62.
31. Eisman JA, Shepard RM, DeLuca HF. Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. Anal Biochem 1977; 80(1): 298-305.
32. Gilbertson TJ, Stryd RP. High-performance liquid chromatographic assay for 25-hydroxyvitamin D3 in serum. Clin Chem 1977; 23(9): 1700-4.
33. Lambert PW, Syverson BJ, Arnaud CD, Spelsberg TC. Isolation and quantitation of endogenous vitamin D and its physiologically important metabolites in human plasma by high pressure liquid chromatography. J Steroid Biochem 1977; 8(9): 929-37.
34. Watson D, Setchell KD, Ross R. Analysis of vitamin D and its metabolites using thermospray liquid chromato - graphy/mass spectrometry. Biomed Chromatogr 1991; 5(4): 153-60.
35. Higashi T, Awada D, Shimada K. Simultaneous De ter - mination of 25-Hydroxyvitamin D2 and 25-Hydro xyvi - tamin D3 in Human Plasma by Liquid Chromatography- Tandem Mass Spectrometry Employing Derivatization with a Cookson-Type Reagent. Biol Pharm Bull 2001; 24(7): 738-43.
36. Vogeser M, Kyriatsoulis A, Huber E, Kobold U. Candidate Reference Method for the Quantification of Circulating 25-Hydroxyvitamin D3 by Liquid Chro ma - tography-Tan dem Mass Spectrometry. Clin Chem 2004; 50(8): 1415-7.
37. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005; 51(9): 1683-90.
38. Højskov CS, Heickendorff L, Møller HJ. High-throughput liquid-liquid extraction and LCMSMS assay for deter - mination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clin Chim Acta 2010; 411(1-2): 114-6.
39. Vogeser M. Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectro - metry. J Steroid Biochem Mol Biol 2010; 121(3-5): 565-73.
40. Kobold U. Approaches to measurement of Vitamin D concentrations - Mass spectrometry. Scand J Clin Lab Invest Suppl 2012; 243: 54-9.
41. Couchman L, Benton CM, Moniz CF. Variability in the analysis of 25-hydroxyvitamin D by liquid chromatography- tandem mass spectrometry: The devil is in the detail. Clin Chim Acta 2012; 413; 1239-43.
42. Bossuyt PMM. Defining biomarker performance and cli - nical validity. Journal of Medical Biochemistry 2011; 30: 193-200.
43. Wootton AW: Improving the measurement of 25-hydroxyvitamin D. Clin Biochem Rev 2005; 26: 33-6.
44. Glendenning P, Noble JM, Taranto M, Musk AA, McGui - ness M, Goldswain PR, Fraser WD, Vasikaran SD. Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the Dia - Sorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases. Ann Clin Biochem 2003; 40(Pt 5): 546-51.
45. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Han - sen KE, DeLuca HF, Drezner MK. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004; 89(7): 3152-7.
46. Snellman G, Melhus H, Gedeborg R, Byberg L, Berglund L, et al. (2010) Determining Vitamin D Status: A Com pa - rison between Commercially Available Assays. PLoS ONE 5(7): e11555. doi:10.1371/journal. pone. 0011555.
47. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography- tandem mass spectrometry methods. Clin Chem 2012; 58(3): 531-42.
48. Van den Ouweland JM, Beijers AM, Demacker PN, van Daal H. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and auto - mated immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878(15-16): 1163-8.
49. Barake M, Daher RT, Salti I, Cortas NK, Al-Shaar L, Habib RH, Fuleihan Gel-H. 25-hydroxyvitamin D assay variations and impact on clinical decision making. J Clin Endocrinol Metab 2012; 97(3): 835-43.
50. Glendenning P, Inderjeeth CA. Vitamin D: Methods of 25 hydroxyvitamin D analysis, targeting at risk populations and selecting thresholds of treatment. Clin Biochem 2012 http://dx.doi.org/10.1016/j.clinbiochem.2012. 04. 0002.
51. Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 2008; 88 (suppl): 511S-512S.